熱門資訊> 正文
DiaMedica Therapeutics私募融资3000万美元
2025-07-21 20:27
- DiaMedica Therapeutics (NASDAQ:DMAC) announced on Monday definitive agreements for a $30.1 million private placement of common shares led by current investors.
- Pursuant to the terms of the securities purchase agreements, the company will issue a total of 8.60 million common shares at $3.50 per share.
- The private placement is expected to close on or about July 23, 2025.
- The company said the proceeds would fund its operations for more than two years and support upcoming milestones including the submission of an investigational new drug (IND) application in the United States for preeclampsia and fetal growth restriction and a Phase 2b study to further evaluate DM199 in both indications, pending IND approval.
- Source: Press Release
More on DiaMedica Therapeutics
- DiaMedica gains on positive mid-stage trial data for lead drug in preeclampsia
- DiaMedica Therapeutics to be included in the Russell 2000 and 3000 indexes
- Seeking Alpha’s Quant Rating on DiaMedica Therapeutics
- Historical earnings data for DiaMedica Therapeutics
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。